Heterocyclic Communications (Feb 2022)

“Click” assembly of novel dual inhibitors of AChE and MAO-B from pyridoxine derivatives for the treatment of Alzheimer’s disease

  • Jia Zhao,
  • Wen Huiyun,
  • Huang Saipeng,
  • Luo Yane,
  • Gao Juanjuan,
  • Wang Ruijie,
  • Wan Kaikai,
  • Xue Weiming

DOI
https://doi.org/10.1515/hc-2022-0002
Journal volume & issue
Vol. 28, no. 1
pp. 18 – 25

Abstract

Read online

This study fast synthesizes numerous functionalized pyridoxines using click chemistry and assayed in vitro as inhibitors of the acetylcholinesterase (AChE), butyrylcholinesterase, and two monoamine oxidase (MAO) isoforms, MAO-A and MAO-B. Most of the obtained compounds demonstrate good AChE and selective MAO-B inhibitory activities in the micromolar range, especially one compound, called 4k5, exhibits excellent inhibitory performance against AChE (IC50 = 0.0816 ± 0.075 μM) and MAO-B (IC50 = 0.039 ± 0.003 μM). Finally, a docking study is carried out, demonstrating potential binding orientations and interactions of the compounds in terms of the AChE and MAO-B active sites.

Keywords